LIVERPOOL SCHOOL OF TROPICAL MEDICINE
- Country
- 🇬🇧United Kingdom
- Ownership
- -
- Established
- 1898-01-01
- Employees
- 650
- Market Cap
- -
- Website
- https://www.lstmed.ac.uk/
Clinical Trials
50
Trial Phases
5 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (37 trials with phase data)• Click on a phase to view related trials
Urine Pneumococcal Antigen Project
- Conditions
- PneumoniaPneumonia - Bacterial
- First Posted Date
- 2025-09-18
- Last Posted Date
- 2025-09-18
- Lead Sponsor
- Liverpool School of Tropical Medicine
- Target Recruit Count
- 350
- Registration Number
- NCT07181200
Respiratory Health and Wellbeing Post Pulmonary Tuberculosis
- Conditions
- Tuberculosis (TB)
- First Posted Date
- 2025-09-17
- Last Posted Date
- 2025-09-17
- Lead Sponsor
- Liverpool School of Tropical Medicine
- Target Recruit Count
- 50
- Registration Number
- NCT07178860
- Locations
- 🇬🇧
Liverpool School of Tropical Medicine, Liverpool, United Kingdom
Monoclonal Antibodies in Children With Severe Anaemia or Severe Malaria to Prevent Malaria After Hospital Discharge
- Conditions
- MalariaSevere MalariaSevere AnaemiaPost Discharge
- Interventions
- Biological: Antimalarial monoclonal antibodiesDrug: Dihydroartemisinin - Piperaquine (DP)Drug: Placebo PDMCBiological: Placebo mMAB
- First Posted Date
- 2025-07-24
- Last Posted Date
- 2025-07-24
- Lead Sponsor
- Liverpool School of Tropical Medicine
- Target Recruit Count
- 398
- Registration Number
- NCT07082205
- Locations
- 🇰🇪
HomaBay County Teaching and Referral Hospital, Kisumu, Nyanza, Kenya
🇰🇪Siaya County Referral Hospital, Kisumu, Nyanza, Kenya
Safety of Antimalarials in the FIRst trimEster
- Conditions
- Malaria, PregnancyMalaria, AntepartumMalaria (Uncomplicated)
- Interventions
- Drug: Pyronaridine-artesunate (PA)Drug: dihydroartemisinin-piperaquine (DP)
- First Posted Date
- 2025-05-08
- Last Posted Date
- 2025-05-08
- Lead Sponsor
- Liverpool School of Tropical Medicine
- Target Recruit Count
- 1510
- Registration Number
- NCT06962319
- Locations
- 🇧🇫
Clinical Research Unit of Nanoro (CRUN), Institut de Recherche en Sciences de la Santé, Direction Régionale de l'Ouest (IRSS-DRO), Nanoro, Burkina Faso
🇰🇪KEMRI Centre for Global Health Research (CGHR), Kisumu, Kenya
🇲🇱Malaria Research and Training Center, University of Sciences, Techniques, and Technologies of Bamako (USTTB),, Bamako, Mali
Characterising the Loss of Haemostasis in Haemorrhagic Fever With Renal Syndrome
- Conditions
- Haemorrhagic Fever With Renal Syndrome
- First Posted Date
- 2025-04-25
- Last Posted Date
- 2025-04-25
- Lead Sponsor
- Liverpool School of Tropical Medicine
- Target Recruit Count
- 62
- Registration Number
- NCT06944275
- Prev
- 1
- 2
- 3
- 4
- 5
- 10
- Next
News
Breakthrough Universal Antivenom Developed Using Blood of Man Bitten 200+ Times
Scientists have developed a groundbreaking antivenom using antibodies from Tim Friede, who voluntarily endured over 200 snake bites and 700 venom injections over nearly 20 years.
£10M Investment in AI-Powered Robotic Labs to Accelerate Infectious Disease Treatment Development
Liverpool School of Tropical Medicine receives £10M funding to establish AI-powered robotic Containment Level 3 laboratories for accelerating development of treatments for high-risk infectious diseases.
Nitisinone Shows Promise as Novel Malaria Control Strategy by Making Human Blood Lethal to Mosquitoes
Researchers have discovered that nitisinone, a drug used to treat rare genetic disorders, makes human blood toxic to mosquitoes that transmit malaria, offering a potential new control strategy.